Key facts
- It has raised $24.0M across 2 recorded rounds; the latest was Early Stage VC ($9.5M) in Dec 2025.
- Notable investors include Alumni Ventures, Felicis, City Light Capital, Contour Venture Partners, Torch Capital — 15 tracked in total.
- Salvo Health has filed 1 Form D with the SEC, most recently Feb 2024 ($15.1M sold to 23 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Salvo Health
Funding rounds
2 roundsAbout Salvo Health
Operator of a virtual health clinic platform intended to treat chronic gut-related illnesses. The company's platform uses a trademarked model of care that considers overall health and contributing factors beyond the gut care for chronic gastrointestinal patients, enabling healthcare providers to identify the root causes and provide personalized and continuous treatment plans to patients.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2021
- Employees
- 48
- Website
- salvohealth.com/
- Ownership
- Privately Held (backing)
Salvo Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Salvo Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Salvo Health in its N-PORT filings yet. We sweep new filings monthly.